NAVER D2SF

Activity from announced rounds

Activity in this selectionUnited States · Mar 31, 2026 · Mar 1, 2026

NAVER D2SF is NAVER’s startup investment organization, identified through official materials for ImpriMed and NdotLight.

Recorded funding activity

ImpriMed combines live-cell drug testing with clinical data. NdotLight generates simulation-ready 3D data, while F4GE structures factory information for industrial buyers. The organization retains its identity separately from NAVER Ventures and the parent.

Sources
Rounds participated in
2
Confirmed lead rounds
0
1 roles undisclosed
New companies
2
First participation on record · 0 follow-on
Funding in participating rounds
—
0 disclosed · full round size, not this investor’s share

By stage

Undisclosed2

By primary sector

Healthtech1
Robotics1

By country

United States2

Rounds

2 in this selection
Soundable Health

Develops AI-powered acoustic analysis for clinical-grade diagnostics through everyday devices

UndisclosedUndisclosed
Role not disclosed
Anyware Robotics

Anyware Robotics builds mobile robots and control software for physically demanding material-handling work in warehouses and industrial facilities.

UndisclosedInvestment
Participant